Obsidio

0 followers


Obsidio is a medical device company pioneering a biomaterial platform technology to enable minimally-invasive occlusion of blood vessels.

Employees

11-50

Links

Org chart

Michael F. Mahoney
Chairman & CEO

Michael F. Mahoney

Collapse
Jodi Eddy
SVP, Chief Information & Digital Officer
Mary Beth Moynihan
SVP, Market Access & Chief Marketing Officer
Vance R. Brown
SVP, General Counsel & Corporate Secretary
Joseph M. Fitzgerald
EVP & Group President, Cardiology
Arthur C. Butcher
EVP & Group President, MedSurg & Asia Pacific
Eric Thépaut
EVP & President, Europe, Middle East & Africa
Jeff Mirviss
EVP & President, Peripheral Interventions
Brad Sorenson
EVP, Global Operations
Wendy Carruthers
EVP, Human Resources
Stephen Morse
SVP & President, Asia Pacific
Scott Olson
SVP & President, Cardiac Rhythm Management & Diagnostics
Michael Jones
SVP & President, Endoscopy
Lance Bates
SVP & President, Interventional Cardiology Therapies
Meghan Scanlon
SVP & President, Urology and Pelvic Health
Rosaleen Burke
SVP, Global Quality & Regulatory
Charlie Attlan
SVP, New Business Development, Corporate Strategy & Portfolio
Kenneth Stein
Senior Vice President & Global Chief Medical Officer